CID 16130235

Wmewdreinnytslihsli-nh2

Structural Information

Molecular Formula
C110H163N29O31S
SMILES
CC[C@H](C)[C@@H](C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)N
InChI
InChI=1S/C110H163N29O31S/c1-13-54(8)87(91(114)152)136-102(163)72(37-52(4)5)126-105(166)80(49-140)134-98(159)76(42-61-48-117-51-121-61)132-107(168)89(56(10)15-3)138-103(164)73(38-53(6)7)127-106(167)81(50-141)135-109(170)90(57(11)142)139-104(165)74(39-58-26-28-62(143)29-27-58)128-99(160)77(43-82(112)144)130-100(161)78(44-83(113)145)133-108(169)88(55(9)14-2)137-96(157)70(31-33-85(148)149)125-93(154)68(25-20-35-118-110(115)116)123-101(162)79(45-86(150)151)131-97(158)75(41-60-47-120-67-24-19-17-22-64(60)67)129-94(155)69(30-32-84(146)147)124-95(156)71(34-36-171-12)122-92(153)65(111)40-59-46-119-66-23-18-16-21-63(59)66/h16-19,21-24,26-29,46-48,51-57,65,68-81,87-90,119-120,140-143H,13-15,20,25,30-45,49-50,111H2,1-12H3,(H2,112,144)(H2,113,145)(H2,114,152)(H,117,121)(H,122,153)(H,123,162)(H,124,156)(H,125,154)(H,126,166)(H,127,167)(H,128,160)(H,129,155)(H,130,161)(H,131,158)(H,132,168)(H,133,169)(H,134,159)(H,135,170)(H,136,163)(H,137,157)(H,138,164)(H,139,165)(H,146,147)(H,148,149)(H,150,151)(H4,115,116,118)/t54-,55-,56-,57+,65-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,87-,88-,89-,90-/m0/s1
InChIKey
MBMNEFVPWSWKOE-HCEOIEJUSA-N
Compound name
(4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-4-amino-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-oxopentanoic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

2418.179 Da
Monoisotopic Mass

-5.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2419.1863 496.9
[M+Na]+ 2441.1682 473.8
[M-H]- 2417.1717 497.2
[M+NH4]+ 2436.2128 482.5
[M+K]+ 2457.1422 475.0
[M+H-H2O]+ 2401.1763 464.5
[M+HCOO]- 2463.1772 475.3
[M+CH3COO]- 2477.1929 470.1
[M+Na-2H]- 2439.1537 502.9
[M]+ 2418.1785 430.7
[M]- 2418.1795 430.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.